In 2022, the overall production value of over-the-counter (OTC) pharmaceuticals in South Korea amounted to around 3.5 trillion South Korean won. This represents an increase from the previous year. Between 2012 and 2022, the production value of OTC drugs increased by 56 percent.
Annual production value of over-the-counter (OTC) pharmaceutical drugs in South Korea from 2012 to 2022 (in trillion South Korean won)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Revenue of pharmaceutical company Recordati 2022, by product
- Basic Statistic Expenditure on nonprescription pharmaceuticals in Sweden 2009-2023
- Premium Statistic Heparin global market size in 2017 and 2023
- Premium Statistic Heparin global market distribution 2016, by region
- Basic Statistic Expenditure on pharmaceuticals in Sweden 2009-2023
- Basic Statistic OTC pain relief treatments sales value in Great Britain 2009-2023
- Basic Statistic Number of prescription drug users in Norway 2021, by active ingredient
- Basic Statistic Number of consumers of pharmaceutical drugs in Italy 2010-2022
- Basic Statistic Number of users of prescription drugs in Norway by ATC main group 2021
- Basic Statistic Value of local pharmaceutical products in Turkey 2010-2022
About the region
10
- Premium Statistic R&D spending of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic R&D spending ratio of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic Sales revenue of JW Pharmaceutical 2014-2022
- Premium Statistic Operating profit of JW Pharmaceutical 2014-2022
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2023
- Premium Statistic Net profit Hanmi Pharmaceutical 2017-2022
- Premium Statistic Sales revenue distribution of JW Pharmaceutical South Korea 2022, by channel
- Basic Statistic Pharmaceutical production value South Korea 2012-2022
- Premium Statistic Leading pharmaceutical companies South Korea 2022, by production value
- Premium Statistic Leading pharmaceutical products South Korea 2022, by production value
Selected statistics
6
- Basic Statistic AstraZeneca's revenue from top product Pulmicort 2006-2023
- Premium Statistic Medicinal market growth worldwide including rebates 2009-2018
- Premium Statistic Expenditure worldwide on diabetes by market 2013-2018
- Premium Statistic Chinese insulin market distribution: leading companies 2011
- Premium Statistic U.S. insulin market distribution: leading companies 2011
- Premium Statistic Standard Unit medicine use per capita in the U.S. 2007-2011
Other regions
10
- Premium Statistic Revenue of the analgesics industry in Italy 2017-2028
- Premium Statistic Genomma Lab: EBITDA 2013-2018
- Premium Statistic Value of pharmaceutical sales in Denmark 2000-2021
- Premium Statistic Leading laxative/stimulant liquid/powder/oil brands in the U.S. 2019
- Premium Statistic Latin America: per capita sales of OTC medicines 2017, by country
- Basic Statistic Washington D.C.'s medical cannabis spending 2018-2024
- Premium Statistic OTC pain relief medicines: breakdown of sales in Great Britain, by category
- Basic Statistic Illinois' medical cannabis sales value U.S. 2018-2024
- Basic Statistic Vermont's medical cannabis sales value U.S. 2018-2024
- Basic Statistic Oregon's medical cannabis sales value U.S. 2018-2024
Related statistics
10
- Premium Statistic Leading countries for pharmaceutical exports South Korea 2022, by export value
- Premium Statistic Leading countries for pharmaceutical imports South Korea 2022, by import value
- Premium Statistic OTC drug products production value South Korea 2012-2022
- Premium Statistic Net income Yuhan 2015-2022
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
- Premium Statistic R&D investment Hanmi Fine Chemical 2017-2022
- Premium Statistic Operating income Yuhan 2015-2022
- Premium Statistic Sales revenue from medicine raw material exports Yuhan 2016-2023
- Premium Statistic Sales revenue from prescription drugs Yuhan 2016-2023
- Premium Statistic Sales revenue from non-prescription drugs Yuhan 2016-2022
Further related statistics
10
- Pfizer's ad spending 2006-2023
- U.S. branded prescription revenue forecast 2009-2015
- Sanofi's total assets 2007-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Sales of Johnson & Johnson 2006-2023 by region
- Johnson & Johnson's number of employees 2004-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
Further Content: You might find this interesting as well
Statistics
- Pfizer's ad spending 2006-2023
- U.S. branded prescription revenue forecast 2009-2015
- Sanofi's total assets 2007-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Sales of Johnson & Johnson 2006-2023 by region
- Johnson & Johnson's number of employees 2004-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
KOSIS. (July 31, 2023). Annual production value of over-the-counter (OTC) pharmaceutical drugs in South Korea from 2012 to 2022 (in trillion South Korean won) [Graph]. In Statista. Retrieved June 01, 2024, from https://www.statista.com/statistics/1323332/south-korea-annual-otc-drugs-production-value/
KOSIS. "Annual production value of over-the-counter (OTC) pharmaceutical drugs in South Korea from 2012 to 2022 (in trillion South Korean won)." Chart. July 31, 2023. Statista. Accessed June 01, 2024. https://www.statista.com/statistics/1323332/south-korea-annual-otc-drugs-production-value/
KOSIS. (2023). Annual production value of over-the-counter (OTC) pharmaceutical drugs in South Korea from 2012 to 2022 (in trillion South Korean won). Statista. Statista Inc.. Accessed: June 01, 2024. https://www.statista.com/statistics/1323332/south-korea-annual-otc-drugs-production-value/
KOSIS. "Annual Production Value of Over-the-counter (Otc) Pharmaceutical Drugs in South Korea from 2012 to 2022 (in Trillion South Korean Won)." Statista, Statista Inc., 31 Jul 2023, https://www.statista.com/statistics/1323332/south-korea-annual-otc-drugs-production-value/
KOSIS, Annual production value of over-the-counter (OTC) pharmaceutical drugs in South Korea from 2012 to 2022 (in trillion South Korean won) Statista, https://www.statista.com/statistics/1323332/south-korea-annual-otc-drugs-production-value/ (last visited June 01, 2024)
Annual production value of over-the-counter (OTC) pharmaceutical drugs in South Korea from 2012 to 2022 (in trillion South Korean won) [Graph], KOSIS, July 31, 2023. [Online]. Available: https://www.statista.com/statistics/1323332/south-korea-annual-otc-drugs-production-value/